Table 1

Patient characteristics at baseline

CharacteristicPlaceboMontelukastBeclomethasone
Subjects n103313314
Age yrs35.5±14.635.9±14.935.5±15.0
Duration of asthma yrs18.7±13.119.0±12.218.2±12.4
FEV1 L2.15±0.642.20±0.662.25±0.65
FEV1 % pred68±1269±1268±11
Daily β‐agonist use puffs·day−15.5±3.95.2±3.75.1±3.3
  • Data are presented as mean±sd

  • FEV1: forced expiratory volume in one second